Literature DB >> 8551577

SR protein splicing factors interact with the Rous sarcoma virus negative regulator of splicing element.

L M McNally1, M T McNally.   

Abstract

Retroviral replication requires that a portion of the primary transcripts generated from proviral DNA be spliced to serve as mRNA for the envelope protein and in Rous sarcoma virus as src mRNA. However, a substantial amount of full-length RNA must be maintained in an unspliced form, as the unspliced RNA serves both as mRNA for structural proteins and virion-associated enzymatic proteins and as genomic RNA for progeny virions. The extent of viral RNA splicing must be finely controlled, since only a narrow range in the ratio of unspliced RNA to spliced RNA is tolerated for optimal replication. A number of cis-acting sequences within the RNA of Rous sarcoma virus play a role in preserving a large pool of unspliced RNA. One such sequence, the negative regulator of splicing (NRS), is of interest because it blocks splicing but is not located near any of the splice junctions. To better understand how this novel element blocks splicing at a distance, we set out to identify host cell factors that interact specifically with this inhibitory sequence. In this study, proteins from nuclear extracts with molecular masses of 26, 36, 44, and 55 kDa were shown by UV cross-linking assays to bind the NRS preferentially. One of them, p55, was also detected in a specific complex with SR protein electrophoretic mobility shift assay. All but p55 have biochemical properties consistent with SR protein splicing factors, and some, but not all, of the total SR proteins purified from HeLa cells cross-link specifically to the NRS. The strongest cross-linking SR protein is SRp30a/b, which is composed of the splicing factors SF2/ASF and SC35. The NRS specifically binds bacterially expressed SF2/ASF, whereas nonfunctional mutants do not. Data indicating that the 36-kDa protein which cross-links in nuclear extracts is SF2/ASF are presented. The data indicate that factors normally required for RNA splicing may be exploited by retroviruses to block splicing.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8551577      PMCID: PMC189925     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  45 in total

1.  Characterization of Rous sarcoma virus intronic sequences that negatively regulate splicing.

Authors:  M T McNally; R R Gontarek; K Beemon
Journal:  Virology       Date:  1991-11       Impact factor: 3.616

Review 2.  Regulation of human immunodeficiency virus replication.

Authors:  B R Cullen
Journal:  Annu Rev Microbiol       Date:  1991       Impact factor: 15.500

3.  Mutations in the regions of the Rous sarcoma virus 3' splice sites: implications for regulation of alternative splicing.

Authors:  S L Berberich; C M Stoltzfus
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

4.  Primary structure of the human splicing factor ASF reveals similarities with Drosophila regulators.

Authors:  H Ge; P Zuo; J L Manley
Journal:  Cell       Date:  1991-07-26       Impact factor: 41.582

5.  Distinct RNA sequences in the gag region of human immunodeficiency virus type 1 decrease RNA stability and inhibit expression in the absence of Rev protein.

Authors:  S Schwartz; B K Felber; G N Pavlakis
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

6.  Control of retroviral RNA splicing through maintenance of suboptimal processing signals.

Authors:  R A Katz; A M Skalka
Journal:  Mol Cell Biol       Date:  1990-02       Impact factor: 4.272

7.  Identification and purification of a 62,000-dalton protein that binds specifically to the polypyrimidine tract of introns.

Authors:  M A García-Blanco; S F Jamison; P A Sharp
Journal:  Genes Dev       Date:  1989-12       Impact factor: 11.361

8.  Intronic sequences and 3' splice sites control Rous sarcoma virus RNA splicing.

Authors:  M T McNally; K Beemon
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

9.  Rev is necessary for translation but not cytoplasmic accumulation of HIV-1 vif, vpr, and env/vpu 2 RNAs.

Authors:  S J Arrigo; I S Chen
Journal:  Genes Dev       Date:  1991-05       Impact factor: 11.361

10.  Functional expression of cloned human splicing factor SF2: homology to RNA-binding proteins, U1 70K, and Drosophila splicing regulators.

Authors:  A R Krainer; A Mayeda; D Kozak; G Binns
Journal:  Cell       Date:  1991-07-26       Impact factor: 41.582

View more
  36 in total

1.  The role of overlapping U1 and U11 5' splice site sequences in a negative regulator of splicing.

Authors:  C S Hibbert; R R Gontarek; K L Beemon
Journal:  RNA       Date:  1999-03       Impact factor: 4.942

2.  The splicing factors 9G8 and SRp20 transactivate splicing through different and specific enhancers.

Authors:  Y Cavaloc; C F Bourgeois; L Kister; J Stévenin
Journal:  RNA       Date:  1999-03       Impact factor: 4.942

3.  Sensitivity of splice sites to antisense oligonucleotides in vivo.

Authors:  H Sierakowska; M J Sambade; D Schümperli; R Kole
Journal:  RNA       Date:  1999-03       Impact factor: 4.942

4.  Retroviral splicing suppressor requires three nonconsensus uridines in a 5' splice site-like sequence.

Authors:  R E Paca; C S Hibbert; C T O'Sullivan; K L Beemon
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

5.  SRp30c is a repressor of 3' splice site utilization.

Authors:  Martin J Simard; Benoit Chabot
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

6.  Multiple interdependent sequence elements control splicing of a fibroblast growth factor receptor 2 alternative exon.

Authors:  F Del Gatto; A Plet; M C Gesnel; C Fort; R Breathnach
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

7.  Retroviral splicing suppressor sequesters a 3' splice site in a 50S aberrant splicing complex.

Authors:  Keith E Giles; Karen L Beemon
Journal:  Mol Cell Biol       Date:  2005-06       Impact factor: 4.272

8.  The negative regulator of splicing element of Rous sarcoma virus promotes polyadenylation.

Authors:  Jeremy E Wilusz; Karen L Beemon
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

9.  Serine/arginine-rich proteins contribute to negative regulator of splicing element-stimulated polyadenylation in rous sarcoma virus.

Authors:  Nicole L Maciolek; Mark T McNally
Journal:  J Virol       Date:  2007-08-01       Impact factor: 5.103

10.  Open reading frame P--a herpes simplex virus gene repressed during productive infection encodes a protein that binds a splicing factor and reduces synthesis of viral proteins made from spliced mRNA.

Authors:  R Bruni; B Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.